Skip to Main Content

Paper Details

Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System.
Inflamm Bowel Dis
4
2021
DNA, GUCA2a, IBD, IBDs, RSS, SPP24, inflammation, inflammatory bowel diseases, patients
Author NameAffiliation
Valerie C WasingerThe University of New South Wales
Robert HirtenIcahn School of Medicine at Mount Sinai
Bruce E SandsIcahn School of Medicine at Mount Sinai
  • 1 - 3

Datasets

Release 1.2